Bioton (LTS:0DTR) E10: zł-0.17 (As of Mar. 2026)


LTS:0DTR Bioton SA LTS:0DTR
69 GF Score
Price zł3.43
GF Value zł4.08
! 3 Warning Signs
View Full Analysis

What is Bioton E10?

Bioton LTS:0DTR 69 E10 is zł-0.17 as of Mar. 2026. GuruFocus rates LTS:0DTR with a GF Score™ of 69/100 and a GF Value™ of zł4.08. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bioton's adjusted earnings per share data for the three months ended in Mar. 2026 was zł-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł-0.17 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 41.90% per year. During the past 5 years, the average E10 Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bioton was 41.90% per year. The lowest was -15.00% per year. And the median was 10.30% per year.

As of today (2026-06-30), Bioton's current stock price is zł3.42829. Bioton's E10 for the quarter that ended in Mar. 2026 was zł-0.17. Bioton's Shiller PE Ratio of today is .


Bioton  (LTS:0DTR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bioton E10 Related Terms


Bioton E10 Historical Data

* Premium members only.

The historical data trend for Bioton's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioton E10 Chart

Bioton Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.66 -1.04 -1.03 -1.35 -0.18

Bioton Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -0.98 -0.91 -0.18 -0.17

LTS:0DTR vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Bioton's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioton's Shiller PE Ratio falls into.


LTS:0DTR
69GF Score
Bioton SA LTS:0DTR
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioton E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioton's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.06/158.3232*158.3232
=-0.060

Current CPI (Mar. 2026) = 158.3232.

Bioton Quarterly Data

per share eps CPI Adj_EPS
201606 -0.050 99.552 -0.080
201609 -0.033 99.064 -0.053
201612 -0.262 100.366 -0.413
201703 -0.126 101.018 -0.197
201706 -0.010 101.180 -0.016
201709 -0.017 101.343 -0.027
201712 -0.082 102.564 -0.127
201803 -0.264 102.564 -0.408
201806 0.770 103.378 1.179
201809 -0.216 103.378 -0.331
201812 -0.118 103.785 -0.180
201903 0.315 104.274 0.478
201906 -1.020 105.983 -1.524
201909 -0.086 105.983 -0.128
201912 -0.459 107.123 -0.678
202003 0.070 109.076 0.102
202006 0.080 109.402 0.116
202009 0.028 109.320 0.041
202012 0.223 109.565 0.322
202103 -0.059 112.658 -0.083
202106 0.039 113.960 0.054
202109 0.054 115.588 0.074
202112 -0.007 119.088 -0.009
202203 -0.037 125.031 -0.047
202206 0.017 131.705 0.020
202209 -0.023 135.531 -0.027
202212 0.062 139.113 0.071
202303 -0.002 145.950 -0.002
202306 0.032 147.009 0.034
202309 -0.051 146.113 -0.055
202312 0.028 147.741 0.030
202403 -0.059 149.044 -0.063
202406 -0.031 150.997 -0.033
202409 -0.039 153.439 -0.040
202412 -0.052 154.660 -0.053
202503 -0.068 157.021 -0.069
202506 0.038 157.509 0.038
202509 0.049 157.998 0.049
202512 0.021 158.323 0.021
202603 -0.060 158.323 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł-0.17 mean?
Bioton (LTS:0DTR) has a E10 of zł-0.17 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioton and its competitors.
Is Bioton's E10 too high?
Bioton's current E10 is zł-0.17. Overall, Bioton has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Bioton's E10 compare to VRTX and REGN?
Bioton's E10 of zł-0.17 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioton and its competitors. Bioton's current E10 is zł-0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioton stock overvalued right now?
Bioton (LTS:0DTR) has a current E10 of zł-0.17. The stock's GF Value™ is zł4.08, compared to a current price of zł3.43 — trading 16% below its estimated fair value. The current E10 is zł-0.17. Bioton's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bioton (LTS:0DTR), the current E10 is zł-0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 16% below its estimated GF Value™ of zł4.08.

Key valuation signals for LTS:0DTR:

  • E10: zł-0.17
  • GF Value™: zł4.08 vs. price of zł3.43 (16% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
69GF Score

Get the complete analysis for LTS:0DTR

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.08
GF Value